β2-Adrenergic receptor-selective agonist clenbuterol prevents Fas- induced liver apoptosis and death in mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 276, Issue 3 39-3, 1999, Pages

  André, Claudine ^a   Couton, Dominique ^a   Gaston, Jesintha ^a   Erraji, Loubna ^a   Renia, Laurent ^a   Varlet, Paule ^a   Briand, Pascale ^a   Guillet, Jean Gérard ^a  

^a INSERM   (France)

Author keywords

Anti Fas monoclonal antibody; C57BL 6 mouse; Transgenic F28 mouse; adrenoceptor antagonist

Indexed keywords

ADENYLATE CYCLASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; CYCLIC AMP; PROPRANOLOL; SALBUTAMOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FAS ANTIGEN; MONOCLONAL ANTIBODY;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BINDING AFFINITY; CELL DEATH; CELL DENSITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; LIVER CELL; LIVER HISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CYTOLOGY; DEATH; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; DRUG RESISTANCE; GENETICS; LIVER; METABOLISM; PHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CLENBUTEROL; DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG SYNERGISM; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA;

EID: 0033092995     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.276.3.g647     Document Type: Article

References (46)

1. Aharoni, D., A. Dantes, M. Oren, and A. Amsterdam. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells. Exp. Cell Res. 218: 271-282, 1995.
2. André, C., L. Erraji, J. Gaston, G. Grimber, P. Briand, and J.-G. Guillet. Transgenic mice carrying the human β2-adrenergic receptor gene with its own promotor overexpress β2-adrenergic receptors in liver. Eur. J. Biochem. 241: 417-424, 1996.
3. Berridge, M. V., A. S. Tan, amd C. J. Hilton. Cyclic adenosine monophosphate promotes cell survival and retards apoptosis in a factor-dependent bone marrow-derived cell line. Exp. Hematol. 21: 269-276, 1998.
4. Bevilacqua, M., E. Norbiato, G. Chebat, G. Baldi, P. Bertora, E. Regalia, G. Colella, L. Gennari, and T. Vago. Changes in alpha-1 and beta-2 adrenoceptor density in human hepatocellular carcinoma. Cancer 67: 2543-2551, 1991.
5. Böhm, M. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Mol. Cell. Biochem. 147: 147-160, 1995.
6. Bour, E. S., L. K. Ward, G. A. Comman, and H. C. Isom. Tumor necrosis factor-α-induced apoptosis in hepatocytes in long-term culture. Am. J. Pathol. 148: 485-495, 1996.
7. Chen, T. C., D. R. Hinton, R. Zidovetzki, and F. M. Hofman. Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab. Invest. 78: 165-174, 1998.
8. Diehl, A. M., S. Q. Yang, P. Cote, and G. S. Wand. Chronic ethanol consumption disturbs G-protein expression and inhibits cyclic AMP-dependent signalling in regenerating rat liver. Hepatology 16: 1212-1219, 1992.
9. Elenkov, I. J., G. Hasko, K. J. Kovacs, and E. S. Vizi. Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α-and β-adrenergic drugs in mice. J. Neuroimmunol. 61: 123-131, 1995.
10. Emorine, L. J., S. Marullo, C. Delavier-Klutchko, S. V. Kaveri, O. Durieu-Trautmann, and A. D. Strosberg. Structure of the gene for human β2-adrenergic receptor: expression and promoter characterization. Proc. Natl. Acad. Sci. USA 84: 6995-6999, 1987.
11. Fladmark, K. E., B. T. Gjertsen, S. O. Døskeland, and O. K. Vintermyr. Fas/APO-1(CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP. Biochem. Biophys. Res. Commun. 232: 20-25, 1997.
12. Hakonarson, H., D. J. Herrick, P. G. Serrano, and M. M. Grunstein. Mechanism of cytokine-induced modulation of β-adrenoceptor responsiveness in airway smooth muscle. J. Clin. Invest. 97: 2593-2600, 1996.
13. Higaki, K., H. Yano, and M. Kojiro. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am. J. Pathol. 149: 429-437, 1996.
14. Hoshi, S., M. Furutani-Seiki, M. Seto, T. Tada, and Y. Asano. Prevention of TCR-mediated apoptosis by the elevation of cAMP. Int. Immunol. 6: 1081-1089, 1994.
15. Huerta-Bahena, J., R. Villalobos-Molina, and J. A. Garcia-Sainz. Roles of alpha-1 and beta-adrenergic receptors in adrenergic responsiveness of liver cells formed after partial hepatectomy. Biochim. Biophys. Acta 763: 112-119, 1983.
16. Katz, M. S., E. M. Dax, and R. I. Gregerman. Beta adrenergic regulation of rat liver glycogenolysis during aging. Exp. Gerontol. 28: 329-340, 1993.
17. Kennedy, N. J., and R. C. Budd. Phosphorylation of FADD/ MORT1 and Fas by kinases that associate with the membrane-proximal cytoplasmic domain of Fas. J. Immunol. 160: 4881-4888, 1998.
18. Kizaki, H., S. Nakada, Y. Ohnishi, Y. Azuma, Y. Mizuno, and T. Tadakuma. Tumour necrosis factor-a enhances cAMP-induced programmed cell death in mouse thymocytes. Cytokine 5: 342-347, 1993.
19. Kondo, T., T. Suda, H. Fukuyama, M. Adachi, and S. Nagata. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3: 409-413, 1997.
20. Kosai, K.-I., K. Matsumoto, S. Nagata, Y. Tsujimoto, and T. Nakamura. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem. Biophys. Res. Commun. 244: 683-690, 1998.
21. Krause, A., A. Steitz, P. von Wichert, and C. Baerwald. Influence of cytokines on the density of β2-adrenergic receptors on peripheral blood mononuclear cells in vitro. Cytokine 7: 273-276, 1995.
22. Lacronique, V., A. Mignon, M. Fabre, B. Viollet, N. Rouquet, T. Molina, A. Porteu, A. Henrion, D. Bouscary, P. Varlet, V. Joulin, and A. Kahn. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 2: 80-86, 1996.
23. Ledda-Columbano, G. M., P. Coni, G. Faa, G. Manenti, and A. Columbano. Rapid induction of apoptosis in rat liver by cycloheximide. Am. J. Pathol. 140: 545-549, 1992.
24. Lee, M. R., M. L. Liou, M. L. Liou, Y. F. Yang, and M. Z. Lai. cAMP analogs prevent activation-induced apoptosis of T cell hybridomas. J. Immunol. 151: 5208-5217, 1993.
25. Leist, M., F. Gantner, I. Bohlinger, P. G. Germann, G. Tiegs, and A. Wendel. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 153: 1778-1788, 1994.
26. Lomo, J., H. K. Blomhoff, K. Beiske, T. Stokke, and E. B. Smeland. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J. Immunol. 154: 1634-1643, 1995.
27. Mackenzie, F. J., J. P. Leonard, and M. L. Cuzner. Changes in lymphocyte β-adrenergic receptor density and noradrenaline content of the spleen are early indicators of immune reactivity in acute experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 23: 93-100, 1989.
28. Mentz, F., M. D. Mossalayi, F. Ouaaz, and P. Debre. Involvement of cAMP in CD3 T cell receptor complex and CD2-mediated apoptosis of human thymocytes. Eur. J. Immunol. 25: 1798-1801, 1995.
29. Messmer, U. K., E. G. Lapetina, and B. Brune. Nitric oxide induced apoptosis in RAW 265.7 macrophages is antagonized by protein kinase C and protein kinase A activating compounds. Mol. Pharmacol. 47: 757-765, 1995.
30. Milano, C. A., L. F. Allen, H. A. Rockman, P. C. Dolber, T. R. McMinn, K. R. Chien, T. D. Johnson, R. A. Bond, and R. J. Lefkowitz. Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor. Science 264: 582-586, 1994.
31. Murray, D. R., S. M. Polizzi, T. Harris, N. Wilson, M. C. Michel, and A. S. Maisel. Prolonged isoproterenol treatment alters immunoregulatory cell traffic and function in the rat. Brain Behav. Immun. 7: 47-62, 1993.
32. Narula, J., N. Haider, R. Vimani, T. G. Disalvo, F. D. Kolodgie, R. J. Hajjar, U. Schmidt, M. J. Semigran, G. W. Dec, and B.-A. Khaw. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335: 1182-1189, 1996.
33. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kagusai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809, 1993.
34. Redondo, C., I. Flores, A. Gonzales, S. Nagata, A. C. Carrera, I. Merida, and A. C. Martinez. Linomide prevents the lethal effect of anti-Fas antibody and reduces Fas-mediated ceramide production in mouse hepatocytes. J. Clin. Invest. 98: 1245-1252, 1996.
35. Rodriguez, I., K. Matsuura, K. Khatib, J. C. Reed, S. Nagata, and P. Vassali. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med. 183: 1031-1036, 1996.
36. Rodriguez, I., K. Matsuura, C. Ody, S. Nagata, and P. Vassali. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. 184: 2067-2071, 1996.
37. Rossi, A. G., J. M. Cousin, I. Dransfield, M. F. Lawson, E. R. Chilvers, and C. Haslett. Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem. Biophys. Res. Commun. 217: 892-899, 1995.
38. Rouquet, N., I. Allemand, G. Grimber, T. Molina, P. Briand, and V. Joulin. Protection of hepatocytes from Fas-mediated apoptosis by a non-transforming SV40 T-antigen mutant. Cell Death Differ. 3: 91-96, 1996.
39. Rouquet, N., I. Allemand, T. Molina, M. Bennoun, P. Briand, and V. Joulin. Fas-dependent apoptosis is impaired by SV40 T-antigen in transgenic liver. Oncogene 11: 1061-1067, 1995.
40. Rouquet, N., J. C. Pages, T. Molina, P. Briand, and V. Joulin. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr. Biol. 6: 1192-1195, 1996.
41. Ruchaud, S., and M. Lanotte. cAMP and death signals in a myeloid leukemia cell: from membrane receptors to nuclear responses: a review. Biochem. Soc. Trans. 25: 410-415, 1997.
42. Van der Pol, T., S. M. Coyle, K. Barbosa, C. C. Braxton, and S. F. Lowry. Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin-10 production during human endotoxemia. J. Clin. Invest. 97: 713-719, 1996.
43. Van Parijs, L., and A. K. Abbas. Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8: 355-361, 1996.
44. Webster, C. R. L., and M. S. Anwer. Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology 27: 1324-1331, 1998.
45. Wu, C.-F., N. H. Bishopric, and R. E. Pratt. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J. Biol. Chem. 272: 14860-14866, 1997.
46. Yue, T.-L., X.-L. Ma, X. Wang, A. M. Romanic, G.-L. Liu, C. Louden, J.-L. Gu, S. Kumar, G. Poste, R. R. Ruffolo, Jr., and G. Z. Feuerstein. Possible involvement of stress-activated protein kinase signalling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ. Res. 82: 166-175, 1998.